TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 48 filers reported holding TFF PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -100.0% | 14,350 | -90.9% | 0.00% | -100.0% |
| Q1 2022 | $1,000,000 | -56.5% | 158,457 | -38.8% | 0.00% | -55.6% |
| Q4 2021 | $2,297,000 | +52.1% | 259,009 | +32.4% | 0.01% | +50.0% |
| Q3 2021 | $1,510,000 | -1.4% | 195,656 | +22.7% | 0.01% | -14.3% |
| Q2 2021 | $1,532,000 | -9.2% | 159,453 | +28.2% | 0.01% | -12.5% |
| Q1 2021 | $1,688,000 | +121.2% | 124,408 | +133.3% | 0.01% | +100.0% |
| Q4 2020 | $763,000 | – | 53,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 220,666 | $4,076,000 | 4.24% |
| Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
| Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
| Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
| PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
| GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
| Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
| 683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |